General Internal Medicine

Obesity Medicine

Questions discussed in this category

In patients with iron deficiency due to history of gastric bypass or IBD, would you consider oral iron therapy if the iron deficiency anemia is mild?

The patient can otherwise tolerate intermittent oral iron therapy.

5 Answers available

How do you counsel someone about metformin use for type 2 diabetes mellitus who is also on a GLP-1 agonist and achieved goal HbA1c, but prefers not to be on metformin anymore?

2 Answers available

Would you consider pharmacotherapy (i.e., GLP1-agonist) or behavioral/nutrition interventions alone in a patient with a remote history of a restrictive eating disorder now presenting with obesity and metabolic complications?

1 Answer available

In what situations would you recommend metformin in addition to aggressive lifestyle interventions for patients with prediabetes and obesity?

Echouffo-Tcheugui et al., PMID 37039787

1 Answer available

Do you recommend restarting GLP-1RA after bariatric surgery if they tolerated it before the surgery?

2 Answers available

How many days prior to elective major surgery do you recommend holding oral GLP 1 R agonist therapy?

4 Answers available

How should we approach the recommendation of intermittent fasting for weight loss in patients with pre-existing cardiovascular conditions, given the observed association of increased CV mortality with eating durations of less than 8 hrs?

Chen & Zhong, AHA/ASA Journals 2024

2 Answers available

Do you recommend routinely monitoring pancreatic markers such as amylase and lipase while receiving GLP1 R agonist or dual agonist therapies to determine their risk of pancreatitis?

2 Answers available

Should GLP-1 agonists be held during chemotherapy?

3 Answers available

Should we be more cautious with the use of GLP 1 R agonist therapy in patients with Type 1 diabetes mellitus and obesity given the increased risk of cardiovascular disease with high body weight variability?

Prattichizzo et al., PMID 39468384

1 Answer available

Is there a role for use of GLP1 R agonist or dual agonist therapy for management of post bariatric hypoglycemia and dumping syndrome?

1 Answer available

Papers discussed in this category

The New England journal of medicine, 2023 Nov 11

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.

BMJ open, 2024 Oct 09

Semaglutide treatment for PRevention Of Toxicity in high-dosE Chemotherapy with autologous haematopoietic stem-cell Transplantation (PROTECT): study protocol for a randomised, double-blind, placebo-controlled, investigator-initiated study.

JAMA network open, 2024 Jul 01

Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes.

The New England journal of medicine, 2022 Apr 21

Calorie Restriction with or without Time-Restricted Eating in Weight Loss.

The lancet. Healthy longevity, 2024 Apr 05

Effects of 3 months of 10-h per-day time-restricted eating and 3 months of follow-up on bodyweight and cardiometabolic health in Danish individuals at high risk of type 2 diabetes: the RESET single-centre, parallel, superiority, open-label, randomised controlled trial.

Diabetes & metabolic syndrome, 2024 Feb 05

Does early time-restricted eating reduce body weight and preserve fat-free mass in adults? A systematic review and meta-analysis of randomized controlled trials.

Cureus, 2023 Oct 16

Comparison of the Efficacy of Metformin and Lifestyle Modification for the Primary Prevention of Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.

Physiological reports, 2019-05

Endocrine implications of bariatric surgery: a review on the intersection between incretins, bone, and sex hormones.

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2024 Oct 29

Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2024 Jun 12

AGA Clinical Practice Update on Management of Iron Deficiency Anemia: Expert Review.

American journal of hematology, 2025 Feb 11

Ferric Carboxymaltose (FCM)-Associated Hypophosphatemia (HPP): A Systematic Review.

General Internal Medicine

Obesity Medicine

Questions discussed in this category

Papers discussed in this category

Related Topics in General Internal Medicine